- Home
- CRVS vs KOPN Comparison
CRVS vs KOPN Comparison
Compare CRVS & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- KOPN
- Stock Information
- Founded
- CRVS 2014
- KOPN 1984
- Country
- CRVS United States
- KOPN United States
- Employees
- CRVS N/A
- KOPN N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- KOPN Semiconductors
- Sector
- CRVS Health Care
- KOPN Technology
- Exchange
- CRVS Nasdaq
- KOPN Nasdaq
- Market Cap
- CRVS 305.4M
- KOPN 255.1M
- IPO Year
- CRVS 2016
- KOPN 1992
- Fundamental
- Price
- CRVS $4.17
- KOPN $1.79
- Analyst Decision
- CRVS Strong Buy
- KOPN Strong Buy
- Analyst Count
- CRVS 4
- KOPN 3
- Target Price
- CRVS $15.00
- KOPN $2.58
- AVG Volume (30 Days)
- CRVS 437.5K
- KOPN 3.4M
- Earning Date
- CRVS 08-12-2025
- KOPN 08-07-2025
- Dividend Yield
- CRVS N/A
- KOPN N/A
- EPS Growth
- CRVS N/A
- KOPN N/A
- EPS
- CRVS N/A
- KOPN N/A
- Revenue
- CRVS N/A
- KOPN $50,841,018.00
- Revenue This Year
- CRVS N/A
- KOPN $8.02
- Revenue Next Year
- CRVS N/A
- KOPN $20.99
- P/E Ratio
- CRVS N/A
- KOPN N/A
- Revenue Growth
- CRVS N/A
- KOPN 28.16
- 52 Week Low
- CRVS $2.47
- KOPN $0.56
- 52 Week High
- CRVS $10.00
- KOPN $2.50
- Technical
- Relative Strength Index (RSI)
- CRVS 46.72
- KOPN 48.49
- Support Level
- CRVS $4.58
- KOPN $1.87
- Resistance Level
- CRVS $4.98
- KOPN $2.21
- Average True Range (ATR)
- CRVS 0.23
- KOPN 0.17
- MACD
- CRVS -0.02
- KOPN -0.04
- Stochastic Oscillator
- CRVS 8.52
- KOPN 19.32
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.